Last reviewed · How we verify
Intravenous ketorolac and oral acetaminophen — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intravenous ketorolac and oral acetaminophen (Intravenous ketorolac and oral acetaminophen) — University of Puerto Rico.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intravenous ketorolac and oral acetaminophen TARGET | Intravenous ketorolac and oral acetaminophen | University of Puerto Rico | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intravenous ketorolac and oral acetaminophen CI watch — RSS
- Intravenous ketorolac and oral acetaminophen CI watch — Atom
- Intravenous ketorolac and oral acetaminophen CI watch — JSON
- Intravenous ketorolac and oral acetaminophen alone — RSS
Cite this brief
Drug Landscape (2026). Intravenous ketorolac and oral acetaminophen — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-ketorolac-and-oral-acetaminophen. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab